申请人:Warner-Lambert Company
公开号:US05288896A1
公开(公告)日:1994-02-22
The present invention is a novel compound which is a 3,5-di-t-butyl-4-hydroxyphenylmethylhydroxylamine or derivative thereof and a pharmaceutically acceptable acid addition or base salt thereof, pharmaceutical composition and methods of use therefor. The invention compounds are now found to have activity as inhibitors of one or both of cyclooxygenase and 5-lipoxygenase providing treatment of conditions advantageously affected by such inhibition including inflammation, arthritis, pain, fever, and the like.
本发明是一种新型化合物,即3,5-二叔丁基-4-羟基苯甲基羟胺或其衍生物,以及其药学上可接受的酸盐或碱盐,以及用途的药物组合物和方法。发明化合物现已发现具有作为环氧化酶和/或5-脂氧合酶抑制剂的活性,提供对受到此类抑制有利影响的疾病的治疗,包括炎症、关节炎、疼痛、发热等。